Post-Transplant Immunosuppression in Autoimmune Liver Disease

Ilyas, 2011, Liver transplantation in autoimmune liver diseases, Best Pract Res Clin Gastroenterol, 25, 765, 10.1016/j.bpg.2011.09.008 Carbone, 2014, Autoimmune liver disease, autoimmunity and liver transplantation, J Hepatol, 60, 210, 10.1016/j.jhep.2013.09.020 Liberal, 2013, Liver transplantation and autoimmune liver diseases, Liver Transplant, 19, 1065, 10.1002/lt.23704 Montano-Loza, 2009, Risk factors for recurrence of autoimmune hepatitis after liver transplantation, Liver Transplant, 15, 1254, 10.1002/lt.21796 Montano-Loza, 2010, Cyclosporine A protects against primary biliary cirrhosis recurrence after liver transplantation, Am J Transplant, 10, 852, 10.1111/j.1600-6143.2009.03006.x Montano-Loza, 2017, Systematic review: recurrent autoimmune liver diseases after liver transplantation, Aliment Pharmacol Ther, 45, 485, 10.1111/apt.13894 Lee, 2020, Increased posttransplant mortality for autoimmune hepatitis compared with other autoimmune liver diseases, J Clin Gastroenterol, 54, 648, 10.1097/MCG.0000000000001271 Ochoa-Allemant, 2020, Long-term outcomes after liver transplantation in the Hispanic population, Liver Int, 40, 437, 10.1111/liv.14248 Heinemann, 2022, Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: experience from the European Liver Transplant Registry, Am J Transplant, 22, 626, 10.1111/ajt.16864 Prados, 1998, Outcome of autoimmune hepatitis after liver transplantation, Transplantation, 66, 1645, 10.1097/00007890-199812270-00013 Milkiewicz, 1999, Recurrence of autoimmune hepatitis after liver transplantation, Transplantation, 68, 253, 10.1097/00007890-199907270-00016 Ratziu, 1999, Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease, J Hepatol, 30, 131, 10.1016/S0168-8278(99)80017-8 Goss, 1997, Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience, Ann Surg, 225, 472, 10.1097/00000658-199705000-00004 Graziadei, 1999, Recurrence of primary sclerosing cholangitis following liver transplantation, Hepatology, 29, 1050, 10.1002/hep.510290427 Vera, 2002, Risk factors for recurrence of primary sclerosing cholangitis of liver allograft, Lancet, 360, 1943, 10.1016/S0140-6736(02)11861-7 Charatcharoenwitthaya, 2007, Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation, Liver Transplant, 13, 1236, 10.1002/lt.21124 Mottershead, 2008, Transplantation in autoimmune liver diseases, World J Gastroenterol, 14, 3388, 10.3748/wjg.14.3388 Campsen, 2008, Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course, Liver Transplant, 14, 181, 10.1002/lt.21313 Manns, 2000, Recurrent autoimmune hepatitis after liver transplantation-when non-self becomes self, Hepatology, 32, 868, 10.1053/jhep.2000.19149 Lee, 2001, Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women, J Gastroenterol Hepatol, 16, 1384, 10.1046/j.1440-1746.2001.02646.x Czaja, 2017, Global disparities and their implications in the occurrence and outcome of autoimmune hepatitis, Dig Dis Sci, 62, 2277, 10.1007/s10620-017-4675-y Hurlburt, 2002, Prevalence of autoimmune liver disease in Alaska Natives, Am J Gastroenterol, 97, 2402, 10.1111/j.1572-0241.2002.06019.x 2015, European association for the study of the, L, EASL Clinical Practice Guidelines: Autoimmune hepatitis. J Hepatol, 63, 971 Montano-Loza, 2007, Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease, Hepatology, 46, 1138, 10.1002/hep.21787 Ferraz-Neto, 2007, Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list, Transplant Proc, 39, 2511, 10.1016/j.transproceed.2007.07.023 Tan, 2005, Early treatment response predicts the need for liver transplantation in autoimmune hepatitis, Liver Int, 25, 728, 10.1111/j.1478-3231.2005.01121.x Neuberger, 2016, Liver transplantation in the United Kingdom, Liver Transplant, 22, 1129, 10.1002/lt.24462 Manns, 2010, Diagnosis and management of autoimmune hepatitis, Hepatology, 51, 2193, 10.1002/hep.23584 Suri, 2020, Mortality on the UNOS waitlist for patients with autoimmune liver disease, J Clin Med, 9 Tanaka, 2020, Autoimmune hepatitis: 2019 update, Gut Liver, 14, 430, 10.5009/gnl19261 Stirnimann, 2019, Recurrent and de novo autoimmune hepatitis, Liver Transplant, 25, 152, 10.1002/lt.25375 Gelson, 2011, The pattern of late mortality in liver transplant recipients in the United Kingdom, Transplantation, 91, 1240, 10.1097/TP.0b013e31821841ba Mack, 2020, Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases, Hepatology, 72, 671, 10.1002/hep.31065 Marudanayagam, 2010, Liver retransplantation in adults: a single-centre, 25-year experience, HPB (Oxford), 12, 217, 10.1111/j.1477-2574.2010.00162.x Gautam, 2006, Recurrence of autoimmune liver disease after liver transplantation: a systematic review, Liver Transplant, 12, 1813, 10.1002/lt.20910 Sucher, 2019, Autoimmune hepatitis-immunologically triggered liver pathogenesis-diagnostic and therapeutic strategies, J Immunol Res, 2019 Doycheva, 2019, Autoimmune hepatitis: current and future therapeutic options, Liver Int, 39, 1002, 10.1111/liv.14062 Puustinen, 2017, Histologic surveillance after liver transplantation due to autoimmune hepatitis, Clin Transplant, 31, 10.1111/ctr.12936 de Quadros Onofrio, 2021, Single-Center North American experience of liver transplantation in autoimmune hepatitis: infrequent indication but good outcomes for patients, J Can Assoc Gastroenterol, 4, 137 Renz, 2002, Liver transplantation for nonviral, nonmalignant diseases:problem of recurrence, World J Surg, 26, 247, 10.1007/s00268-001-0213-2 Duclos-Vallee, 2003, A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence, Gut, 52, 893, 10.1136/gut.52.6.893 Krishnamoorthy, 2016, Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease, Liver Transplant, 22, 34, 10.1002/lt.24323 Montano-Loza, 2022, Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation, J Hepatol, 77, 84, 10.1016/j.jhep.2022.01.022 Thurairajah, 2013, Late acute liver allograft rejection; a study of its natural history and graft survival in the current era, Transplantation, 95, 955, 10.1097/TP.0b013e3182845f6c D'Antiga, 2020, Coronaviruses and immunosuppressed patients: the facts during the third epidemic, Liver Transplant, 26, 832, 10.1002/lt.25756 Vierling, 2020, Immunosuppressive treatment regimens in autoimmune hepatitis: systematic reviews and meta-analyses supporting American association for the study of liver diseases guidelines, Hepatology, 72, 753, 10.1002/hep.31407 Llado, 2006, Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study, J Hepatol, 44, 710, 10.1016/j.jhep.2005.12.010 Rowe, 2008, The impact of disease recurrence on graft survival following liver transplantation: a single centre experience, Transpl Int, 21, 459, 10.1111/j.1432-2277.2007.00628.x Alvarez, 1999, International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis, J Hepatol, 31, 929, 10.1016/S0168-8278(99)80297-9 Hennes, 2008, Simplified criteria for the diagnosis of autoimmune hepatitis, Hepatology, 48, 169, 10.1002/hep.22322 Campsen, 2008, Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal, Liver Transplant, 14, 1281, 10.1002/lt.21525 Balan, 2008, Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the national institute of diabetes and digestive and kidney diseases liver transplantation database, Hepatology, 48, 878, 10.1002/hep.22435 Reich, 2000, Liver transplantation for autoimmune hepatitis, Hepatology, 32, 693, 10.1053/jhep.2000.16666 Ayata, 2000, Liver transplantation for autoimmune hepatitis: a long-term pathologic study, Hepatology, 32, 185, 10.1053/jhep.2000.9077 O'Grady, 2010, Phenotypic expression of recurrent disease after liver transplantation, Am J Transplant, 10, 1149, 10.1111/j.1600-6143.2010.03080.x Khalaf, 2007, Liver transplantation for autoimmune hepatitis: a single-center experience, Transplant Proc, 39, 1166, 10.1016/j.transproceed.2007.02.030 Leung, 2020, Review article: pathophysiology and management of primary biliary cholangitis, Aliment Pharmacol Ther, 52, 1150, 10.1111/apt.16023 Lu, 2018, Factors associated with prevalence and treatment of primary biliary cholangitis in United States health systems, Clin Gastroenterol Hepatol, 16, 1333, 10.1016/j.cgh.2017.10.018 Lleo, 2016, Evolving trends in female to male incidence and male mortality of primary biliary cholangitis, Sci Rep, 6, 10.1038/srep25906 Gao, 2020, Clinical management of primary biliary cholangitis-strategies and evolving trends, Clin Rev Allergy Immunol, 59, 175, 10.1007/s12016-019-08772-7 Onofrio, 2019, A practical review of primary biliary cholangitis for the gastroenterologist, Gastroenterol Hepatol (N Y), 15, 145 Lindor, 2019, Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases, Hepatology, 69, 394, 10.1002/hep.30145 Aguilar, 2018, Current status of liver transplantation for primary biliary cholangitis, Clin Liver Dis, 22, 613, 10.1016/j.cld.2018.03.011 Martin, 2014, Evaluation for liver transplantation in adults: 2013 practice guideline by the American association for the study of liver diseases and the American society of transplantation, Hepatology, 59, 1144, 10.1002/hep.26972 Poupon, 2010, Primary biliary cirrhosis: a 2010 update, J Hepatol, 52, 745, 10.1016/j.jhep.2009.11.027 Galoosian, 2020, Clinical updates in primary biliary cholangitis: trends, epidemiology, diagnostics, and new therapeutic approaches, J Clin Transl Hepatol, 8, 49 Kashyap, 2010, Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database, J Gastrointest Surg, 14, 1362, 10.1007/s11605-010-1256-1 Chen, 2020, Risk factors for recurrent autoimmune liver diseases after liver transplantation: a meta-analysis, Medicine (Baltim), 99 Li, 2021, Risk factors for recurrent primary biliary cirrhosis after liver transplantation: a systematic review and meta-analysis, Dig Liver Dis, 53, 309, 10.1016/j.dld.2020.12.005 Corpechot, 2020, Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis, J Hepatol, 73, 559, 10.1016/j.jhep.2020.03.043 Berlakovich, 1996, The importance of the effect of underlying disease on rejection outcomes following orthotopic liver transplantation, Transplantation, 61, 554, 10.1097/00007890-199602270-00007 Milkiewicz, 2000, Increased incidence of chronic rejection in adult patients transplanted for autoimmune hepatitis: assessment of risk factors, Transplantation, 70, 477, 10.1097/00007890-200008150-00014 Uemura, 2008, Late acute rejection after liver transplantation impacts patient survival, Clin Transplant, 22, 316, 10.1111/j.1399-0012.2007.00788.x Satapathy, 2017, Outcomes of liver transplant recipients with autoimmune liver disease using long-term dual immunosuppression regimen without corticosteroid, Transplant Direct, 3, e178, 10.1097/TXD.0000000000000693 Jacob, 2006, Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients, Clin Transplant, 20, 211, 10.1111/j.1399-0012.2005.00471.x Hayashi, 1998, Allograft rejection after liver transplantation for autoimmune liver diseases, Liver Transplant Surg, 4, 208, 10.1002/lt.500040313 Levitsky, 2017, Acute rejection increases risk of graft failure and death in recent liver transplant recipients, Clin Gastroenterol Hepatol, 15, 584, 10.1016/j.cgh.2016.07.035 Pedersen, 2021, Ursodeoxycholic acid decreases incidence of primary biliary cholangitis and biliary complications after liver transplantation: a meta-analysis, Liver Transplant, 27, 866, 10.1002/lt.25935 Bosch, 2015, Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence, J Hepatol, 63, 1449, 10.1016/j.jhep.2015.07.038 Van de Water, 1996, Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis, Hepatology, 24, 1079, 10.1002/hep.510240517 Duclos-Vallee, 2009, Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation, Liver Transplant, 15, S25, 10.1002/lt.21916 Nevens, 2018, PBC-transplantation and disease recurrence, Best Pract Res Clin Gastroenterol, 34–35, 107, 10.1016/j.bpg.2018.09.001 Montano-Loza, 2019, Factors associated with recurrence of primary biliary cholangitis after liver transplantation and effects on graft and patient survival, Gastroenterology, 156, 96, 10.1053/j.gastro.2018.10.001 Neuberger, 1982, Recurrence of primary biliary cirrhosis after liver transplantation, N Engl J Med, 306, 1, 10.1056/NEJM198201073060101 Sanchez, 2003, The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation, Transplantation, 76, 1583, 10.1097/01.TP.0000090867.83666.F7 Robertson, 2007, Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis, Hepatology, 45, 977, 10.1002/hep.21624 Silveira, 2010, Recurrent primary biliary cirrhosis after liver transplantation, Am J Transplant, 10, 720, 10.1111/j.1600-6143.2010.03038.x Dmitrewski, 1996, Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression, J Hepatol, 24, 253, 10.1016/S0168-8278(96)80001-8 Wong, 1993, Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression, J Hepatol, 17, 284, 10.1016/S0168-8278(05)80206-5 Mazariegos, 1997, Weaning of immunosuppression in liver transplant recipients, Transplantation, 63, 243, 10.1097/00007890-199701270-00012 Chapman, 2019, Primary sclerosing cholangitis, Medicine, 47, 799, 10.1016/j.mpmed.2019.09.004 Hirschfield, 2013, Primary sclerosing cholangitis, Lancet, 382, 1587, 10.1016/S0140-6736(13)60096-3 Karlsen, 2017, Primary sclerosing cholangitis - a comprehensive review, J Hepatol, 67, 1298, 10.1016/j.jhep.2017.07.022 de Vries, 2015, Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis, World J Gastroenterol, 21, 1956, 10.3748/wjg.v21.i6.1956 Palmela, 2018, Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features, Gut Liver, 12, 17, 10.5009/gnl16510 Weismuller, 2017, Patient Age, sex, and inflammatory bowel disease phenotype Associate with course of primary sclerosing cholangitis, Gastroenterology, 152, 1975, 10.1053/j.gastro.2017.02.038 Irles-Depe, 2020, Impact of preexisting inflammatory bowel disease on the outcome of liver transplantation for primary sclerosing cholangitis, Liver Transplant, 26, 1477, 10.1002/lt.25838 Bakhshi, 2020, An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort, J Gastroenterol, 55, 523, 10.1007/s00535-020-01663-1 Tabibian, 2018, Primary sclerosing cholangitis, Part 1: epidemiology, etiopathogenesis, clinical features, and treatment, Gastroenterol Hepatol (N Y), 14, 293 Salguero, 2003, Recurrence of primary biliary cirrhosis after liver transplantation, Transplant Proc, 35, 721, 10.1016/S0041-1345(03)00064-2 Wiesner, 2001, Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease, Best Pract Res Clin Gastroenterol, 15, 667, 10.1053/bega.2001.0212 Vesterhus, 2020, Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities, J Gastroenterol, 55, 588, 10.1007/s00535-020-01681-z Sirpal, 2017, Primary sclerosing cholangitis: diagnostic and management challenges, Clin Exp Gastroenterol, 10, 265, 10.2147/CEG.S105872 Bayable, 2021, Ethnicity-specific differences in liver transplant outcomes among adults with primary sclerosing cholangitis: 2005-2017 united Network for organ sharing/organ procurement and transplantation Network, J Clin Exp Hepatol, 11, 30, 10.1016/j.jceh.2020.06.004 Graziadei, 1999, Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis, Hepatology, 30, 1121, 10.1002/hep.510300501 Henson, 2017, Outcomes of liver retransplantation in patients with primary sclerosing cholangitis, Liver Transplant, 23, 769, 10.1002/lt.24703 Ravikumar, 2015, Risk factors for recurrent primary sclerosing cholangitis after liver transplantation, J Hepatol, 63, 1139, 10.1016/j.jhep.2015.07.005 Hildebrand, 2016, Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: a retrospective multicenter analysis, Liver Transplant, 22, 42, 10.1002/lt.24350 Lindstrom, 2018, Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: a Nordic Multicentre Study, Scand J Gastroenterol, 53, 297, 10.1080/00365521.2017.1421705 Martin, 2017, Timing, management, and outcomes of liver transplantation in primary sclerosing cholangitis, Semin Liver Dis, 37, 305, 10.1055/s-0037-1608655 Cholongitas, 2008, Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation, Liver Transplant, 14, 138, 10.1002/lt.21260 Steenstraten, 2019, Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation, Aliment Pharmacol Ther, 49, 636, 10.1111/apt.15148 Fosby, 2012, Recurrence and rejection in liver transplantation for primary sclerosing cholangitis, World J Gastroenterol, 18, 1, 10.3748/wjg.v18.i1.1 Jeyarajah, 1998, Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?, Transplantation, 66, 1300, 10.1097/00007890-199811270-00006 Khettry, 2003, Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study, Hum Pathol, 34, 1127, 10.1053/j.humpath.2003.07.015 Egawa, 2009, Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience, Dig Dis Sci, 54, 1347, 10.1007/s10620-009-0773-9 Melum, 2011, Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci, Nat Genet, 43, 17, 10.1038/ng.728 Alexander, 2008, Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation, Liver Transplant, 14, 245, 10.1002/lt.21394 Mason, 2013, Systematic investigation of elevated cholestatic enzymes during the third posttransplant month, Liver Transplant, 19, S23, 10.1002/lt.23742 Alabraba, 2009, A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts, Liver Transplant, 15, 330, 10.1002/lt.21679 Joshi, 2013, The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis, Liver Int, 33, 53, 10.1111/j.1478-3231.2011.02677.x Verdonk, 2006, Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection, Scand J Gastroenterol, 41, 205, 10.1080/00365520500206293 Liberal, 2016, Recurrence of autoimmune liver disease and inflammatory bowel disease after pediatric liver transplantation, Liver Transplant, 22, 1275, 10.1002/lt.24490 Lindor, 2015, ACG clinical guideline: primary sclerosing cholangitis, Am J Gastroenterol, 110, 646, 10.1038/ajg.2015.112 Lindor, 2009, High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis, Hepatology, 50, 808, 10.1002/hep.23082 Gish, 2001, Autoimmune liver disease. Current standards, future directions, Clin Liver Dis, 5, 287, 10.1016/S1089-3261(05)70167-7 Beuers, 2005, Overlap syndromes, Semin Liver Dis, 25, 311, 10.1055/s-2005-916322 Bhanji, 2013, Liver transplantation for overlap syndromes of autoimmune liver diseases, Liver Int, 33, 210, 10.1111/liv.12027 Gupta, 2001, De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation, Transplantation, 71, 664, 10.1097/00007890-200103150-00016 Miyagawa-Hayashino, 2004, Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation, Transplantation, 78, 128, 10.1097/01.TP.0000132328.33460.43 Cho, 2011, De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution's experience, Transplant Proc, 43, 2394, 10.1016/j.transproceed.2011.05.030 Hernandez, 2001, Autoimmune hepatitis as a late complication of liver transplantation, J Pediatr Gastroenterol Nutr, 32, 131, 10.1097/00005176-200102000-00007 Kerkar, 1998, De-novo autoimmune hepatitis after liver transplantation, Lancet, 351, 409, 10.1016/S0140-6736(97)06478-7 Montano-Loza, 2012, Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation, Liver Int, 32, 1426, 10.1111/j.1478-3231.2012.02832.x Venick, 2007, Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis, Am J Transplant, 7, 955, 10.1111/j.1600-6143.2006.01717.x Salcedo, 2002, Response to steroids in de novo autoimmune hepatitis after liver transplantation, Hepatology, 35, 349, 10.1053/jhep.2002.31167 Berardi, 2007, High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?, Gut, 56, 237, 10.1136/gut.2006.092064 Aguilera, 2014, De novo autoimmune hepatitis after interferon treatment in a liver transplant recipient with common variable immunodeficiency, Dig Liver Dis, 46, 663, 10.1016/j.dld.2014.03.002 Sebagh, 2013, Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adults, Transplantation, 96, 670, 10.1097/TP.0b013e31829eda7f Demetris, 2016, Comprehensive update of the banff working group on liver allograft pathology: introduction of antibody-mediated rejection, Am J Transplant, 16, 2816, 10.1111/ajt.13909 Mieli-Vergani, 2011, Autoimmune liver diseases in children - what is different from adulthood?, Best Pract Res Clin Gastroenterol, 25, 783, 10.1016/j.bpg.2011.10.007 Floreani, 2013, Autoimmune hepatitis: contrasts and comparisons in children and adults - a comprehensive review, J Autoimmun, 46, 7, 10.1016/j.jaut.2013.08.004